Clinical Report: HPG Axis Suppression in Women with Cushing Syndrome

Overview

This study evaluates the hypothalamic-pituitary-gonadal (HPG) axis status in 137 women with Cushing syndrome (CS), revealing significant hormonal alterations associated with the severity of hypercortisolism. Notably, ectopic ACTH syndrome (EAS) was linked to the most pronounced disruptions in reproductive hormone levels.

Background

Cushing syndrome is a serious endocrine disorder characterized by excessive glucocorticoids, leading to various complications, including reproductive dysfunction. Women are particularly affected, yet there is a lack of focused research on the HPG axis in this population.

Data Highlights

Key Findings

• Women with EAS showed significantly elevated ACTH and cortisol levels.
• Testosterone levels were markedly elevated in EAS patients, while LH and FSH levels were reduced.
• Linear regression indicated a positive correlation between serum cortisol and testosterone.
• Inverse correlations were found between cortisol and LH/FSH, especially in postmenopausal women.
• Plasma androgens demonstrated superior diagnostic power in distinguishing Cushing's disease from adrenal CS.
• The gonadal axis was more susceptible to hypercortisolism compared to the thyroid axis.

Clinical Implications

Understanding the severity-dependent effects on the HPG axis may aid in better management of reproductive health in these patients.

Conclusion

This study demonstrates the significant impact of hypercortisolism on the HPG axis in women with Cushing syndrome, particularly in those with ectopic ACTH syndrome.

Related Resources & Content

1. Frontiers | A retrospective study of severity-dependent HPG Axis suppression by glucocorticoids in Chinese women with Cushing syndrome
2. Cushing syndrome | Nature Reviews Disease Primers
3. Disease activity and maternal-fetal outcomes in pregnant women with cushing's syndrome: a systematic review and meta‑analysis
4. The Journal of Clinical Endocrinology & Metabolism — Cortisol Secretion's Impact on Pheochromocytomas and Paragangliomas: Clinical and Perioperative Considerations
5. The Journal of Clinical Endocrinology & Metabolism — Management Strategies for Patients Experiencing Cyclical Cushing Syndrome
6. The Journal of Clinical Endocrinology & Metabolism — Impact of Cushing Syndrome Treatment on Lipid Abnormalities: A Systematic Review and Meta-Analysis
7. The Journal of Clinical Endocrinology & Metabolism — Biochemical Management of Cushing's Syndrome: Treatment Outcomes in a Large Cohort from a Single Tertiary Care Center
8. Cortisol Secretion's Impact on Pheochromocytomas and Paragangliomas: Clinical and Perioperative Considerations
9. Management Strategies for Patients Experiencing Cyclical Cushing Syndrome
10. Impact of Cushing Syndrome Treatment on Lipid Abnormalities: A Systematic Review and Meta-Analysis
11. Cushing syndrome | Nature Reviews Disease Primers
12. Disease activity and maternal-fetal outcomes in pregnant women with cushing's syndrome: a systematic review and meta‑analysis
13. Frontiers | A retrospective study of severity-dependent HPG Axis suppression by glucocorticoids in Chinese women with Cushing syndrome